Pershing Square Tontine Holdings - PSTH - Share Chat

Interest rates damage growth companies as it eats at speculative profits. But for us, this means market caps of growth companies (for example Stripe :wink:) are lower. So with Bill being sat on $5B, he can negotiate a better deal

1 Like

Below $25 in premarket :grimacing: Hopefully it stays this low till payday (I doubt it though)

Personally, I can see it falling to between $22 and $23 – all SPACs are getting hit hard and are dropping nearer to their NAV. Unless, of course, a deal is announced in the next couple of weeks.

In the meantime, it’s all about dollar-cost averaging.

1 Like

I know no fundamentals of the company have changed but… Guh.

Brutal day today, congrats to those with cash to average out

PSTH PTSD

5 Likes

Too right. I’m sticking to watching Gme today instead. My average is 135ish so I’m in the sweet spot right now.

1 Like

And we are back in the green, managed to pick up a lot at 23.56 to average down. Luckily had some spare cash to hand before payday Monday :sweat_smile:. Come on silver fox make all this worth it.

3 Likes

PSTH my only green today! :sweat_smile:

1 Like

Road back to 30

20210305_210406

1 Like

image

2 Likes

Summary of Jackie Reses’ Appearance on CNBC today, 5 March, at 13:40 PST

She was not asked about PSTH and did not comment on it. Remember, she has fiduciary duties not to disclose certain information.

Jackie was first asked about her thoughts of the SPAC industry.

  • She stated she sees material dislocation in the SPAC market. She doesn’t anticipate seeing all-time highs again as we saw in February (looking broadly at the SPAC market as a whole).

  • Stated she doesn’t see the SPAC bubble “bursting,” just small changes. Further stated we’re seeing so many targets skewed towards long-term growth.

  • Outside of the SPAC market, stated the expectation of inflation is driving growth of business in the market.

  • Stated if she were an investor, she’d be very selective. Also stated she recognizes the public is taking a pause in the SPAC market.
    Jackie was then asked about finance technology, specifically, whether there are more gains in the market to come, or whether the finance technology market is about to face a pushback.

  • Noted there is 1.5T capital invested in fintech, but 16T in financial companies.

  • Stated we should expect to see a wholesale transition over the next 15 years as fintech takes over banking. Explained this is because traditional banks are not meeting the needs of consumers, specifically, the simple, consolidated banking and transacting requirements.

6 Likes
1 Like

PSTH got a mention in the Sunday Times this morning

3 Likes

It’s looks like Jackie could be filling out a 13D form :eyes:

There’s the 13D form - https://www.sec.gov/Archives/edgar/data/1781870/000091957419005885/d8365842_13-d.htm

Purpose of form 13D Source

(Schedule 13D Definition)

• When a person or group acquires 5% or more of a company’s shares, they must report it to the Securities and Exchange Commission.
• Among the questions Schedule 13D asks is the purpose of the transaction, such as a takeover or merger.
• If the beneficial owner’s holdings change by 1% or more, they must amend their Schedule 13D

And it looks like their SEC filings page is down. Confirmation bias or is it actually being updated due to new developments?

https://pstontine.com/investor-relations/#sec

1 Like

My gut would say it’s just their RSS url being broken but my heart says… it’s DA tomorrow and it’s Stripe!

4 Likes

https://www.telegraph.co.uk/technology/2021/03/08/wall-street-blank-cheque-craze-may-crash/amp/

Be wary of spacs

With the exception of this, I think all of mine have all crashed close to NAV already …

Not really, SPACs have a timeframe (generally 2 years) within which they must merge, if they don’t then shareholders are reimbursed the IPO price - fees. If anything getting a SPAC at IPO price or lower is actually less of a gamble than investing in an existing company.

6% down in premarket… buckle up for another turbulent day